Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-016870
Filing Date
2019-06-13
Accepted
2019-06-13 18:00:33
Documents
1
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17134
  Complete submission text file 0000899243-19-016870.txt   18664
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIODELIVERY SCIENCES INTERNATIONAL 801 CORPORATE CENTER DRIVE -SUITE 210 RALEIGH NC 27607
Business Address
Sirgo Mark A (Reporting) CIK: 0001301715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 19897188